Real-World Impact of a BRCA Testing Protocol in Portugal
Mariana Malheiro1,2, Bruno Silva3, João Rosa4
1Medical Oncology, Hospital CUF Tejo, Lisbon, PRT.
Cureus
|July 28, 2025
Summary
Implementing a standardized protocol significantly increased BRCA genetic testing rates by over 100% in Portuguese oncology centers, improving access to early cancer diagnosis and personalized treatments.
Area of Science:
- Oncology
- Genetics
- Public Health
Background:
- BRCA1 and BRCA2 gene mutations are linked to increased risks for breast, ovarian, prostate, and pancreatic cancers.
- Underutilization of BRCA genetic testing in Portugal hinders early diagnosis and personalized cancer care.
- International guidelines exist but adherence is suboptimal.
Purpose of the Study:
- To assess BRCA testing practices in three Portuguese oncology centers.
- To evaluate the impact of a standardized testing protocol on BRCA testing rates.
- To provide the first multicenter real-world data on BRCA testing in Portugal.
Main Methods:
- A quality-improvement study was conducted across three ULS centers.
- Baseline BRCA testing data was collected.
- A standardized protocol based on international guidelines was developed and implemented.
- Post-implementation testing rates were evaluated.
Main Results:
- Average monthly BRCA tests increased from 14.16 to 29.66, a 109.4% rise.
- All participating centers demonstrated improved testing rates.
- ULS Amadora Sintra showed the largest relative increase (388.8%).
Conclusions:
- A protocol-driven approach effectively enhances adherence to BRCA genetic testing guidelines.
- Standardization and local engagement are crucial for advancing precision oncology.
- The study highlights the need for improved BRCA testing uptake in Portugal.
Related Concept Videos
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K


